Junshi Biosciences Receives NMPA Approval of sNDA for Toripalimab in Combination with Paclitaxel and Cisplatin in First-Line Treatment of Advanced or Distant Metastatic Esophageal Squamous Cell Carcinoma

–5th approved indication by NMPA significantly expands eligible patient population SHANGHAI, China, May 16, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the China National Medical Products Administration (NMPA) has […]

Continue Reading

BluChip Launches an Innovative NFT Marketplace Uniquely Tethering the Value of Museum Artwork to NFTs

BluChip Pioneers the “Swappable” BluChip NFT Marketplace logo PALM SPRINGS, Calif., May 16, 2022 (GLOBE NEWSWIRE) — BluChip today introduced its unique platform enabling the purchase of non-fungible tokens (NFTs) that are tethered to an original fine art painting or sculpture. With this ability, NFTs now have actual physical value specific to world-class artwork, making them more […]

Continue Reading

Crowdz Secures $10M Strategic Investment, Led by Citi and Global Cleantech Capital

The investment will enable Crowdz to expand its ability to bring accessible working capital to small businesses. Crowdz Blockchain Technology CAMPBELL, Calif., May 16, 2022 (GLOBE NEWSWIRE) — Small and mid-sized enterprise (SME) finance platform Crowdz has secured $10 million in investment, led by Citi and Global Cleantech Capital, with participation from Bold Capital Partners, […]

Continue Reading

Economists sound the alarm over UK’s post-Brexit finance plans

Published by Reuters UK LONDON (Reuters) – More than 50 economists warned on Monday that Britain’s post-Brexit plans to boost the competitiveness of its huge finance industry risked creating the kind of problems that led to the global financial crisis. The government, seeking to use its “Brexit freedoms”, announced this month that it would require […]

Continue Reading

Philips showcases ultra-low contrast PCI solutions at EuroPCR 2022

May 16, 2022 Co-registration of real-time intravascular ultrasound and/or iFR physiological assessment data onto motion-compensated angiograms aids percutaneous coronary intervention (PCI) procedure planning, quantitative lesion measurement, stent choice and sizing, and therapy assessment Reduced need for contrast media enables broader access to PCI for patients at risk of acute kidney injury Ultra-low contrast PCI procedures […]

Continue Reading